Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10287303 Compositions and methods for inhibiting arginase activity

Patent 10287303 was granted and assigned to Calithera Biosciences on May, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Calithera Biosciences
Calithera Biosciences
Date Filed
December 22, 2017
Date of Patent
May 14, 2019
Patent Applicant
Calithera Biosciences
Calithera Biosciences
Patent Application Number
15853310
Patent Citations Received
‌
US Patent 11661422 Tricyclic urea compounds as JAK2 V617F inhibitors
0
‌
US Patent 11691971 Naphthyridinone compounds as JAK2 V617F inhibitors
0
‌
US Patent 11753413 Substituted pyrrolo[2,1-f][1,2,4]triazine compounds as JAK2 V617F inhibitors
‌
US Patent 11767323 Tricyclic pyridone compounds as JAK2 V617F inhibitors
‌
US Patent 11958861 Spirocyclic lactams as JAK2 V617F inhibitors
0
‌
US Patent 12084430 Tricyclic urea compounds as JAK2 V617F inhibitors
0
‌
US Patent 11780840 Tricyclic urea compounds as JAK2 V617F inhibitors
‌
US Patent 11389464 Arginase inhibitors as therapeutics
0
‌
US Patent 11919908 Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors
0
‌
US Patent 11021495 Compositions and methods for inhibiting arginase activity
Patent Inventor Names
Darren Whitehouse
0
Eric B. Sjogren
0
Gunnar E. Jagdmann, Jr.
0
Jim Li
0
Lene Raunkjær Petersen
0
Lijing Chen
0
Michael Van Zandt
0
Roland J. Billedeau
0
Timothy F. Stanton
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10287303
Patent Primary Examiner
‌
Erich A Leeser

Find more entities like US Patent 10287303 Compositions and methods for inhibiting arginase activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo